In B-lymphoma cells, transfection of JAM-A increased NODAL expression, while treatment with specific TGF-β/NODAL/Smad inhibitor SB431542 abrogated JAM-A-induced NODAL upregulation and lymphoma cell invasion (Fig. 4D and Supplementary Figure S3A). This evidence concerns the gene F11R and lymphoma.